Accelerating Clinical Research Across Europe
Our Mission
Oxurion (Euronext Brussels: OXUR) is a Belgian holding company building a leading group of clinical research organizations (CROs) in Europe. By acquiring and integrating specialist CROs across the full clinical research value chain — from study design, regulatory affairs and clinical operations to data management, biostatistics, medical writing, pharmacovigilance, real-world evidence and market access — Oxurion creates an integrated, end-to-end platform, supporting drug and device development from early phases to post-approval, serving the pharmaceutical, biotechnology and medtech industries.
Our Commitment
We are committed to building a resilient, multi-company CRO platform that integrates clinical development, evidence generation and market access — supporting faster, smarter and higher-quality decision-making across the product lifecycle.
Building a European Clinical Data Platform
Oxurion is a Euronext Brussels-listed holding company focused on building a next-generation European platform dedicated to clinical data, biometrics and AI-driven clinical research services.
Through a targeted buy-and-build strategy, Oxurion aims to consolidate high-value CRO and clinical technology capabilities across Europe.
Our Vision
Oxurion’s ambition is to build a leading European clinical data ecosystem combining technology, regulatory expertise and operational excellence to accelerate the development of next-generation therapies.
Platform Highlights
72% controlling stake in Axiodis CRO
Proprietary Next-Gen eCRF & Data Management System: Exagis
7,000+ patient files processed
20+ active partners
Full clinical data expertise
AI integration roadmap
Active acquisition strategy
Scalable platform
Axiodis CRO
Axiodis is a French clinical research organization specialized in biometrics, clinical data management and biostatistics. Through its proprietary Exagis platform and regulatory expertise, Axiodis supports biotech, pharmaceutical, medtech and academic sponsors in the execution of complex clinical studies.
Visit axiodis.com →